share_log

Arcutis Biotherapeutics | CORRESP: CORRESP

Arcutis Biotherapeutics | CORRESP:信函

美股SEC公告 ·  02/07 03:01

Moomoo AI 已提取核心訊息

Arcutis Biotherapeutics, Inc. has formally requested the United States Securities and Exchange Commission (SEC) to accelerate the effective date of its Registration Statement on Form S-3, as per a letter dated February 6, 2024. The company seeks to have the Registration Statement, with the number 333-276794, become effective by 4:00 p.m. Washington, D.C. time on February 8, 2024, or as soon as possible thereafter. This request was made under Rule 461 of the Securities Act of 1933, as amended. Arcutis has indicated that their counsel, Latham & Watkins LLP, may request a different effective time by phone. The company has asked the SEC to confirm the effectiveness of the Registration Statement orally with their counsel following its declaration.
Arcutis Biotherapeutics, Inc. has formally requested the United States Securities and Exchange Commission (SEC) to accelerate the effective date of its Registration Statement on Form S-3, as per a letter dated February 6, 2024. The company seeks to have the Registration Statement, with the number 333-276794, become effective by 4:00 p.m. Washington, D.C. time on February 8, 2024, or as soon as possible thereafter. This request was made under Rule 461 of the Securities Act of 1933, as amended. Arcutis has indicated that their counsel, Latham & Watkins LLP, may request a different effective time by phone. The company has asked the SEC to confirm the effectiveness of the Registration Statement orally with their counsel following its declaration.
根據2024年2月6日的一封信,Arcutis Biotherapeutics, Inc.已正式要求美國證券交易委員會(SEC)加快其S-3表格註冊聲明的生效日期。該公司力求使編號爲333-276794的註冊聲明在華盛頓特區時間2024年2月8日下午4點之前或之後儘快生效。該請求是根據經修訂的1933年《證券法》第461條提出的。Arcutis表示,他們的律師瑞生和沃特金斯律師事務所可能會通過電話要求不同的生效時間。該公司已要求美國證券交易委員會在聲明後與其律師口頭確認註冊聲明的有效性。
根據2024年2月6日的一封信,Arcutis Biotherapeutics, Inc.已正式要求美國證券交易委員會(SEC)加快其S-3表格註冊聲明的生效日期。該公司力求使編號爲333-276794的註冊聲明在華盛頓特區時間2024年2月8日下午4點之前或之後儘快生效。該請求是根據經修訂的1933年《證券法》第461條提出的。Arcutis表示,他們的律師瑞生和沃特金斯律師事務所可能會通過電話要求不同的生效時間。該公司已要求美國證券交易委員會在聲明後與其律師口頭確認註冊聲明的有效性。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息